As you probably gathered from an earlier post of mine, I like caffeine! Haha, well following up on that theme, I have found a second story which confirms why I like to have a few cups (or more) of java in the morning… Well, coffee lovers unite and rejoice because we need to have no shame, and in fact should spread the love via probate.
Decaf May Increase RA Risk
Many people who eliminate caffeine from their diets as part of their healthy lifestyles may actually be increasing their risk of rheumatoid arthritis (RA), an autoimmune disease that causes inflammation of the joints and internal organs.
According to a recent corporate study that included more than 31,000 women between the ages of 55-69, test subjects who consumed four or more cups of decaffeinated coffee a day were more than twice as likely to develop RA, compared to women who did not drink decaffeinated coffee. No link was found between regular coffee intake and an increase in RA risk.
Researchers could only speculate about the mechanisms behind these findings, but they pointed out that the blame could rest with an old decaffeination process. Before the late 1980s, the decaffeination process involved chemicals and chemical solvents that are no longer used.
And, when you’re having that first cup of Joe (as my mom called it), you should drink some pomegranate juice and enjoy a multi-vitamin:
Antioxidants and Zinc Help Fight Macular Degeneration
High levels of antioxidants and zinc significantly reduce the risk of advanced age-related macular degeneration (AMD) and its associated vision loss. These same nutrients had no significant effect on the development or progression of cataracts, according to a nationwide clinical trial.
Scientists found that people at high risk of developing advanced stages of AMD, a leading cause of vision loss, lowered their risk by about 25% when treated with a high-dose combination of vitamin C, vitamin E, beta-carotene, and zinc.
Currently, treatment for advanced AMD is limited. These nutrients may delay the progression to advanced AMD in people who are at high risk-those with intermediate AMD in one or both eyes, or those with advanced AMD in one eye.
And we can hold out hope for a better tomorrow because of advancements like this:
New Molecule Kills Cancer by Attacking Blood Vessels
Researchers have discovered a molecule that they hope could be a radical new therapy to fight cancer. The molecule, which the researchers call “icon,” not only attacks cancer growths but also forces the cancer itself to produce more of the cancer-destroying molecules.
The researchers, Alan Garen and Zhiwei Hu of Yale University, completed successful tests on mice that had human forms of prostate cancer and melanoma. Icon directly attacked the blood vessels that fed the tumors, thereby eliminating the cancer. While other drugs have been tested to limit the growth of blood vessels in tumors, icon is the first that actually destroys the blood vessels by attacking their lining cells.
Though excited, the scientists cautioned that “from mice to men, that is a big jump.” Testing on human patients will hopefully begin next Spring, after the Food and Drug Administration approves the tests.